Results for 'IO'
Find oncology podcasts about IO — interviews, panel discussions, and expert-led audio on cancer innovation. Open any episode for listening options and show notes; switch tabs to explore articles, partners, and community members.
Dr. Rebecca Previs
Advancing Endometrial Cancer Care with Molecular Profiling
endometrial cancer care, prognosis, precision treatment
How molecular profiling of GOG258 is changing advanced endometrial cancer care—insights on POL-E, prognosis, and precision treatment.
May 14th • 32 mins listen
Kirk Shepard
Why Relationships Define Medical Affairs Leadership
relationships, medical affairs, tom caravela
Join Tom Caravela as he uncovers what truly sets medical affairs leaders apart. Learn how relationships, expertise, and proactive strategies power lasting careers in oncology and beyond. Perfect for MSLs and anyone aiming to lead in life sciences. Tune in now!
Apr 14th • 23 mins listen
Monty Pal
Reengineering CAR T for Solid Tumors: What Glioblastoma Has Taught Us with Christine Brown, Ph.D.
City of Hope, Academic Research, CAR T-cell, Solid Tumor, Glioblastoma, brain tumor
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Christine Brown, Ph.D., Deputy Director of the T Cell Research Laboratory at City of Hope, joins Monty Pal, M.D., F.A.S.C.O., to discuss how years of research in glioblastoma, one of the most aggressive and difficult brain ca…
Apr 6th • 42 mins listen
Monty Pal
The Long Game of Cancer Genomics: John Carpten, Ph.D., on Building Precision Oncology that Reaches Patients
City of Hope, Academic Research, genomics, genome mapping, TGen, Translational Genomics Research Institute, spatial biology, AI, access
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, John Carpten, Ph.D., Chief Scientific Officer at City of Hope, discusses the evolution of cancer genomics—how early genome mapping enabled today’s targeted approaches and what infrastructure and equity considerations will…
Mar 23rd • 56 mins listen
Monty Pal
How Engineered Antibodies and Next Generation Imaging Tools are Reshaping Cancer Care with Anna Wu, Ph.D.
City of Hope, Academic Research, engineered antibodies, PET, imaging, radioisotope, CEA directed agent, PSCA targeted radiopharmaceutical, pancreatic cancer, prostate cancer
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Anna Wu, Ph.D., Chair of the Department of Immunology and Theranostics at City of Hope, joins host Monty Pal, M.D., for an engaging discussion on how innovations in antibody engineering and imaging are improving clinicians’…
Mar 9th • 42 mins listen
Monty Pal
Unlocking the Future of Cancer Care: Precision Medicine, AI and the Patient Voice with Dr. Stacy Gray
City of Hope, Academic Research, precision medicine, AI
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Stacy Gray, M.D., A.M., Director of Clinical and Scientific Strategy and Vice President of System Strategy at City of Hope, joins Monty Pal, M.D., F.A.S.C.O. in an engaging discussion of how precision medicine and AI are tran…
Feb 23rd • 43 mins listen
Kirk Shepard
Humans Beyond the Algorithm: Hiring for Oncology’s Future
Stacy Benefiel, AI, Talent, Workforce Innovation, Human Resources, HR
In episode 4 of Oncology Voice Network Podcast, Host Dr. Kirk Shepard welcomes Stacey Benefiel, PharmD, Head of Global Clinical and Medical Affairs at Canopy, for a candid exploration of what it really takes to build the future oncology workforce.
Mar 3rd • 23 mins listen
Jesus Izaguirre-Carbonell
Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing
Quest, Diagnostics, MRD, minimal residual testing, precision, biomarker
Dr. Thomas Slavin breaks down how ultrasensitive MRD testing supports better cancer treatment decisions and enables earlier, more personalized interventions.
Jul 7th • 19 mins listen
Monty Pal
Three Leaders, One Vision: Principles for Transforming Cancer Care Delivery
City of Hope, Academic Research, ASCO, precision, AI, dose strategy
Dr. Walter Stadler & Dr. Alan Bryce share how City of Hope is building a national system for smarter research, greater access, and better cancer care.
Jun 23rd • 43 mins listen
Monty Pal
At the Crossroads of Cancer and Metabolism
City of Hope, Academic Research, metabolic dysfunction, GLP-1
Dr. Charles Brenner explores the metabolic links between cancer, diabetes, NAD, and the future of liver-focused therapies.
Jul 7th • 37 mins listen
Rebecca Previs
Tumor-Agnostic Therapies and the Future of HER2 in Oncology
diagnostic, precision oncology, tumor agnostic, breast cancer, gastric cancer, biomarker
What tumor-agnostic approvals mean for HER2, NGS, and precision oncology — and how they’re changing treatment across cancer types.
Jun 8th • 20 mins listen
Rebecca Previs
Rethinking How We Track and Treat Cancer
diagnostic, genomics, breast cancer, antibody drug conjugate, ADC, breast cancer, lung cancer, biomarker
HER2, HER3, and MRD: Drs. Previs and Green break down ASCO highlights and what they mean for the future of cancer diagnostics.
Jul 13th • 19 mins listen
Rebecca Previs
Why Comprehensive Testing Matters - Ken Schlosser’s Lung Cancer Story
diagnostic, biomarker, lung cancer, advocacy, precision
Biomarker testing helped Ken Schlosser live with stage IV lung cancer for over 6 years. Here's how it shaped his care plan from the start.
Jul 31st • 23 mins listen
Rebecca Previs
Redefining Ovarian Cancer Care with Biomarkers
diagnostic, ovarian cancer, biomarker, tumor biology
Exploring ovarian cancer, biomarkers HRD & RB1, and how Labcorp innovations are advancing precision oncology.
Sep 7th • 14 mins listen
Rebecca Previs
Empowering Breast Cancer Patients: Biomarker Breakthroughs & Self-Advocacy
diagnostic, breast cancer, digital, biomarker, genetic testing, advocacy
Suzanne Garner’s journey shows how education, advocacy, and technology are reshaping breast cancer patient care and clinical trial access.
Oct 19th • 26 mins listen
Rebecca Previs
FFPE: The Workhorse Behind NGS Testing
biomarker, sequencing, diagnostics, translational research, precision
Exploring FFPE’s impact on precision oncology, NGS innovation, and the future of tissue stewardship in cancer care with leading Labcorp experts.
Jan 28th • 33 mins listen
Rebecca Previs
Navigating the Future of CDXs in Oncology
precision oncology, companion diagnostics, CDx, biomarker, precision medicine
CDX expert Dawn McHugh joins Dr. Rebecca Previs to unpack the role of companion diagnostics in precision oncology and the future of cancer care.
Feb 18th • 26 mins listen
Monty Pal
Asking the Impossible: How Bold Questions are Unlocking Diabetes Biggest Breakthroughs
City of Hope, Academic Research, diabetes, microbiome
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Dr. Monty Pal sits down with Dr. Alberto Pugliese, Samuel Rahbar Chair in Diabetes & Drug Discovery, chair of the Department of Diabetes Immunology and director of The Wanek Family Project for Type 1 Diabetes. Tune in to disc…
Nov 10th • 51 mins listen
Monty Pal
How Mentorship Sparks Innovation: A Conversation with Dr. Wesley Yip
City of Hope, Academic Research, urological oncology, microbiome, mentor
In the season 3 finale episode of On the Edge of Breakthrough: Voices of Cancer Research, Dr. Monty Pal welcomes Wesley Yip, M.D., Assistant Professor, Division of Urology and Urologic Oncology, Department of Surgery at City of Hope. The duo explores Dr. Yip’s career journey sparked by an early i…
Jan 6th • 35 mins listen
Monty Pal
How Team Science Fuels Cancer Breakthroughs: A Conversation with Dr. Marcel van den Brink
City of Hope, Academic Research, T cell, microbiome
In the season 4 premiere of On the Edge of Breakthrough: Voices of Cancer Research, Monty Pal, M.D., F.A.S.C.O., welcomes Marcel van den Brink, M.D., Ph.D., President of City of Hope Los Angeles and City of Hope National Medical Center, Chief Physician Executive and the Deana and Steve Campbell Phys…
Feb 10th • 57 mins listen